Trial | Genotype | Lifespan* | % increase | n | P value** |
---|---|---|---|---|---|
1 | N2, Blank(RNAi) | 63.7 | Â | 39 | Â |
 | N2, pmk-1(RNAi) | 42.4 | −33.4 | 73 | < 0.005 |
 | N2, daf-16(RNAi) | 55.9 | −12.2 | 47 | > 0.05 |
 | N2, daf-2(RNAi) | 140.0 | +119.8 | 42 | < 0.005 |
2 | N2, Blank(RNAi) | 65.3 | Â | 77 | Â |
 | N2, pmk-1(RNAi) | 48.5 | −25.8 | 79 | < 0.005 |
 | N2, daf-16(RNAi) | 55.6 | −14.8 | 71 | > 0.05 |
3 | N2, Blank(RNAi) | 75.0 | Â | 81 | Â |
 | N2, pmk-1(RNAi) | 38.6 | −48.5 | 84 | < 0.005 |
 | N2, daf-2(RNAi) | 125.3 | +67.1 | 51 | < 0.005 |
4 | N2, Blank(RNAi) | 53.9 | Â | 51 | Â |
 | N2, daf-16(RNAi) | 56.7 | +5.2 | 79 | > 0.05 |
 | N2, daf-2(RNAi) | 117.4 | +118.0 | 75 | < 0.005 |
5 | N2, Blank(RNAi) | 62.1 | Â | 63 | Â |
 | daf-16(mu86), Blank(RNAi) | 57.5 | −7.3 | 39 | > 0.05 |
 | daf-16(mu86), daf-2(RNAi) | 65.4 | +5.3 | 58 | > 0.05 |
6 | N2, Blank(RNAi) | 72.7 | Â | 68 | Â |
 | daf-16(mu86), Blank(RNAi) | 62.1 | −14.6 | 70 | > 0.05 |
 | daf-16(mu86), daf-2(RNAi) | 62.5 | −14.1 | 68 | > 0.05 |
7 | N2 | 64.6 | Â | 87 | Â |
 | ins-7(tm1907) | 76.3 | +18.3 | 83 | < 0.01 |
8 | N2 | 64.0 | Â | 88 | Â |
 | ins-7(tm1907) | 77.1 | +20.6 | 75 | < 0.05 |